Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 9 Lung Neoplasms 6 Carcinoma, Non-Small-Cell Lung 4 Prostatic Neoplasms 3 Barrett Esophagus 3 Stomach Neoplasms 2 Recurrence 2 Rectal Neoplasms 2 Pancreatic Neoplasms 2 Neoplasms 2 Multiple Pulmonary Nodules 2 Melanoma 2 Glioma 2 Colorectal Neoplasms 2 Adenocarcinoma of Lung 2 Triple Negative Breast Neoplasms 1 Thyroid Nodule 1 Thyroid Neoplasms 1 Spinal Fractures 1 Solitary Pulmonary Nodule 1 Smoking Cessation 1 Small Cell Lung Carcinoma 1 Skin Neoplasms 1 Phyllodes Tumor 1 Osteoporosis 1 Nevus 1 Neoplastic Cells, Circulating 1 Neoplasm Metastasis 1 Lymphoma, Follicular 1 Lung Diseases 1

Interventions

Cisplatin 258 Radiotherapy 193 Cetuximab 151 pembrolizumab 123 Docetaxel 97 Fluorouracil 92 Carboplatin 80 Paclitaxel 78 Radiotherapy, Intensity-Modulated 72 Surveys and Questionnaires 46 Nivolumab 42 Drug Therapy 34 Radiation 33 Blood Specimen Collection 27 Erlotinib Hydrochloride 26 Gemcitabine 25 Immunohistochemistry 22 Gefitinib 22 Cyclophosphamide 22 Surgical Procedures, Operative 21 Standard of Care 20 durvalumab 19 Pemetrexed 19 Magnetic Resonance Spectroscopy 19 Radiosurgery 17 Capecitabine 17 Chemotherapy, Adjuvant 16 Celecoxib 16 Biopsy 16 atezolizumab 15

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Head and Neck Neoplasms × Diagnostic Imaging × Clear all

NCT02478138 2024-04-15

SLN Mapping

University Health Network, Toronto

Phase NA Completed

Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡